Cargando…
Cardiac Regeneration using Growth Factors: Advances and Challenges
Myocardial infarction is the most significant manifestation of ischemic heart disease and is associated with high morbidity and mortality. Novel strategies targeting at regenerating the injured myocardium have been investigated, including gene therapy, cell therapy, and the use of growth factors. Gr...
Autores principales: | Rebouças, Juliana de Souza, Santos-Magalhães, Nereide Stela, Formiga, Fabio Rocha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053196/ https://www.ncbi.nlm.nih.gov/pubmed/27355588 http://dx.doi.org/10.5935/abc.20160097 |
Ejemplares similares
-
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19
por: Formiga, Fabio Rocha, et al.
Publicado: (2021) -
Nanotechnology and COVID-19: quo vadis?
por: Tavares, João Lima, et al.
Publicado: (2022) -
Vascular Endothelial Growth Factor-Delivery Systems for Cardiac Repair: An Overview
por: Simón-Yarza, Teresa, et al.
Publicado: (2012) -
Direct Cardiac Reprogramming: Advances in Cardiac Regeneration
por: Chen, Olivia, et al.
Publicado: (2015) -
Editorial: Advanced Therapies for Cardiac Regeneration
por: Boffito, Monica, et al.
Publicado: (2021)